Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1282, 2001-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
What's the real cost of preventing chronic disease in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. :
Amiodarone worth it for cardiomyopathy vs ICDs in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 421, 2003-01 ,pp. :
Improving uptake of breast cancer screening worth it in the US?
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :
Improving uptake of breast cancer screening worth it in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. :
Amiodarone worth it for cardiomyopathy vs ICDs in the US?
Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. :